Literature DB >> 16737965

Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm.

Xiufeng Song1, Dayanidhi Raman, Eugenia V Gurevich, Sergey A Vishnivetskiy, Vsevolod V Gurevich.   

Abstract

Arrestins bind active phosphorylated G protein-coupled receptors, terminating G protein activation. Receptor-bound non-visual arrestins interact with numerous partners, redirecting signaling to alternative pathways. Arrestins also have nuclear localization and nuclear exclusion signals and shuttle between the nucleus and the cytoplasm. Constitutively shuttling proteins often redistribute their interaction partners between the two compartments. Here we took advantage of the nucleoplasmic shuttling of free arrestins and used a "nuclear exclusion assay" to study their interactions with two proteins involved in "life-and-death" decisions in the cell, the kinase JNK3 and the ubiquitin ligase Mdm2. In human embryonic kidney 293 cells green fluorescent protein (GFP)-JNK3 and GFP-Mdm2 predominantly localize in the nucleus, whereas visual arrestin, arrestin2(Q394L) mutant equipped with the nuclear exclusion signal, and arrestin3 localize exclusively to the cytoplasm. Coexpression of arrestins moves both GFP-JNK3 and GFP-Mdm2 to the cytoplasm. Arrestin mutants "frozen" in the basal conformation are the most efficacious. Thus, arrestins in their basal state interact with JNK3 and Mdm2, suggesting that arrestins are likely "preloaded" with their interaction partners when they bind the receptor. Robust interaction of free arrestins with JNK3 and Mdm2 and their ability to regulate subcellular localization of these proteins may play an important role in the survival of photoreceptors and other neurons, as well as in retinal and neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737965      PMCID: PMC2430869          DOI: 10.1074/jbc.M603659200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation.

Authors:  M Han; V V Gurevich; S A Vishnivetskiy; P B Sigler; C Schubert
Journal:  Structure       Date:  2001-09       Impact factor: 5.006

2.  An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation.

Authors:  S A Vishnivetskiy; C Schubert; G C Climaco; Y V Gurevich; M G Velez; V V Gurevich
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

3.  Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3.

Authors:  W E Miller; P H McDonald; S F Cai; M E Field; R J Davis; R J Lefkowitz
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

4.  Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.

Authors:  P H McDonald; C W Chow; W E Miller; S A Laporte; M E Field; F T Lin; R J Davis; R J Lefkowitz
Journal:  Science       Date:  2000-11-24       Impact factor: 47.728

Review 5.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

6.  Visual arrestin binding to microtubules involves a distinct conformational change.

Authors:  Susan M Hanson; Derek J Francis; Sergey A Vishnivetskiy; Candice S Klug; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2006-02-06       Impact factor: 5.157

7.  Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin.

Authors:  Susan M Hanson; Derek J Francis; Sergey A Vishnivetskiy; Elena A Kolobova; Wayne L Hubbell; Candice S Klug; Vsevolod V Gurevich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-17       Impact factor: 11.205

8.  Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds.

Authors:  L M Luttrell; F L Roudabush; E W Choy; W E Miller; M E Field; K L Pierce; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

9.  An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2.

Authors:  S C Evans; M Viswanathan; J D Grier; M Narayana; A K El-Naggar; G Lozano
Journal:  Oncogene       Date:  2001-07-05       Impact factor: 9.867

10.  Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.

Authors:  S K Shenoy; P H McDonald; T A Kohout; R J Lefkowitz
Journal:  Science       Date:  2001-10-04       Impact factor: 47.728

View more
  75 in total

Review 1.  Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2012-06-01       Impact factor: 4.315

Review 2.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

Review 3.  Extensive shape shifting underlies functional versatility of arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Curr Opin Cell Biol       Date:  2013-11-16       Impact factor: 8.382

4.  Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes.

Authors:  Luis E Gimenez; Stefanie Babilon; Lizzy Wanka; Annette G Beck-Sickinger; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

5.  Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors.

Authors:  Luis E Gimenez; Seunghyi Kook; Sergey A Vishnivetskiy; M Rafiuddin Ahmed; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 6.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

7.  Arrestin binding to calmodulin: a direct interaction between two ubiquitous signaling proteins.

Authors:  Nan Wu; Susan M Hanson; Derek J Francis; Sergey A Vishnivetskiy; Marc Thibonnier; Candice S Klug; Menachem Shoham; Vsevolod V Gurevich
Journal:  J Mol Biol       Date:  2006-10-03       Impact factor: 5.469

8.  Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity.

Authors:  Susan M Hanson; Whitney M Cleghorn; Derek J Francis; Sergey A Vishnivetskiy; Dayanidhi Raman; Xiufeng Song; K Saidas Nair; Vladlen Z Slepak; Candice S Klug; Vsevolod V Gurevich
Journal:  J Mol Biol       Date:  2007-02-22       Impact factor: 5.469

9.  S-Nitrosylation of β-Arrestins Biases Receptor Signaling and Confers Ligand Independence.

Authors:  Hiroki Hayashi; Douglas T Hess; Rongli Zhang; Keiki Sugi; Huiyun Gao; Bea L Tan; Dawn E Bowles; Carmelo A Milano; Mukesh K Jain; Walter J Koch; Jonathan S Stamler
Journal:  Mol Cell       Date:  2018-05-03       Impact factor: 17.970

10.  Engineering visual arrestin-1 with special functional characteristics.

Authors:  Sergey A Vishnivetskiy; Qiuyan Chen; Maria C Palazzo; Evan K Brooks; Christian Altenbach; Tina M Iverson; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.